46 related articles for article (PubMed ID: 19690522)
1. Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients.
Capurso G; Falconi M; Panzuto F; Rinzivillo M; Boninsegna L; Bettini R; Corleto V; Borgia P; Pederzoli P; Scarpa A; Delle Fave G
Am J Gastroenterol; 2009 Dec; 104(12):3034-41. PubMed ID: 19690522
[TBL] [Abstract][Full Text] [Related]
2. Family history of diabetes and pancreatic cancer as risk factors for pancreatic cancer: the PACIFIC study.
Austin MA; Kuo E; Van Den Eeden SK; Mandelson MT; Brentnall TA; Kamineni A; Potter JD
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1913-7. PubMed ID: 23966578
[TBL] [Abstract][Full Text] [Related]
3. Incidentally Found Rectal Carcinoid Tumor in a 46-Year-Old Female: The Potential for Complications and the Importance of Screening Guidelines.
Lapides R; Shah A; Bal S
Cureus; 2024 Feb; 16(2):e55163. PubMed ID: 38558605
[TBL] [Abstract][Full Text] [Related]
4. Role of Mediterranean diet in endocrine diseases: a joint overview by the endocrinologist and the nutritionist.
Barrea L; Verde L; Annunziata G; Camajani E; Caprio M; Sojat AS; Marina LV; Guarnotta V; Colao A; Muscogiuri G
J Endocrinol Invest; 2024 Jan; 47(1):17-33. PubMed ID: 37697017
[TBL] [Abstract][Full Text] [Related]
5. Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): Further insights into an under recognized entity.
Osher E; Geva R; Wolf I; Tordjman K; Klausner J; Sofer Y; Scapa E; Shibolet O; Ben-Ami Shor D; Bar-Yishay I; Lubezky N; Goykhman Y; Lahat G; Yakir O; Pelles S; Aizic A; Blachar A; Stern N; Greenman Y
J Clin Transl Endocrinol; 2023 Sep; 33():100322. PubMed ID: 37663867
[TBL] [Abstract][Full Text] [Related]
6. Generation of an Obese Diabetic Mouse Model upon Conditional
Gaspar TB; Jesus TT; Azevedo MT; Macedo S; Soares MA; Martins RS; Leite R; Rodrigues L; Rodrigues DF; Cardoso L; Borges I; Canberk S; Gärtner F; Miranda-Alves L; Lopes JM; Soares P; Vinagre J
Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37296979
[TBL] [Abstract][Full Text] [Related]
7. Analyses of sex-based clinicopathological differences among patients with gastrointestinal neuroendocrine neoplasms in Europe.
Jann H; Krieg S; Krieg A; Eschrich J; Luedde T; Kostev K; Loosen S; Roderburg C
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7557-7563. PubMed ID: 36971798
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Relationship between Obesity, Metabolic Syndrome and Neuroendocrine Neoplasms.
Lan X; Fazio N; Abdel-Rahman O
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422290
[TBL] [Abstract][Full Text] [Related]
9. Impact of Diabetes Mellitus in Patients with Pancreatic Neuro-Endocrine Tumors: Causes, Consequences, and Future Perspectives.
Hernandez-Rienda L; Del Olmo-García MI; Merino-Torres JF
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422243
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study.
Feola T; Puliani G; Sesti F; Modica R; Centello R; Minotta R; Cannavale G; Di Meglio S; Di Vito V; Lauretta R; Appetecchia M; Colao A; Lenzi A; Isidori AM; Faggiano A; Giannetta E
J Endocrinol Invest; 2022 Apr; 45(4):849-857. PubMed ID: 35040099
[TBL] [Abstract][Full Text] [Related]
11. Implications of neuroendocrine tumor and diabetes mellitus on patient outcomes and care: a matched case-control study.
Kusne YN; Kosiorek HE; Buras MR; Verona PM; Coppola KE; Rone KA; Cook CB; Karlin NJ
Future Sci OA; 2021 Feb; 7(5):FSO684. PubMed ID: 34046189
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic Cancer Exposome Profile to Aid Early Detection and Inform Prevention Strategies.
Monroy-Iglesias MJ; Dolly S; Sarker D; Thillai K; Van Hemelrijck M; Santaolalla A
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33924591
[TBL] [Abstract][Full Text] [Related]
13. Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.
Barrea L; Muscogiuri G; Modica R; Altieri B; Pugliese G; Minotta R; Faggiano A; Colao A; Savastano S
Front Endocrinol (Lausanne); 2021; 12():649496. PubMed ID: 33815296
[TBL] [Abstract][Full Text] [Related]
14. Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms.
Zhuge X; Wang Y; Chen X; Guo C
Front Endocrinol (Lausanne); 2020; 11():615082. PubMed ID: 33424776
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective.
Muscogiuri G; Altieri B; Albertelli M; Dotto A; Modica R; Barrea L; Fanciulli G; Feola T; Baldelli R; Ruggeri RM; Gallo M; Guarnotta V; Malandrino P; Messina E; Venneri MA; Giannetta E; Ferone D; Colao A; Faggiano A;
Endocrine; 2020 Aug; 69(2):441-450. PubMed ID: 32468269
[TBL] [Abstract][Full Text] [Related]
16. DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors.
Cives M; Partelli S; Palmirotta R; Lovero D; Mandriani B; Quaresmini D; Pelle' E; Andreasi V; Castelli P; Strosberg J; Zamboni G; Falconi M; Silvestris F
Sci Rep; 2019 Dec; 9(1):18614. PubMed ID: 31819132
[TBL] [Abstract][Full Text] [Related]
17. Disseminated Well-Differentiated Gastro-Entero-Pancreatic Tumors Are Associated with Metabolic Syndrome.
Santos AP; Castro C; Antunes L; Henrique R; Cardoso MH; Monteiro MP
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31533348
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic carcinoma underlying a complex presentation in late pregnancy: a case report.
Shi AW; Shen XF; Ding HJ; Liu YQ; Meng L; Kalionis B
J Med Case Rep; 2018 Dec; 12(1):369. PubMed ID: 30551739
[TBL] [Abstract][Full Text] [Related]
19. The incidence and survival of pancreatic cancer by histology, including rare subtypes: a nation-wide cancer registry-based study from Taiwan.
Chang JS; Chen LT; Shan YS; Chu PY; Tsai CR; Tsai HJ
Cancer Med; 2018 Nov; 7(11):5775-5788. PubMed ID: 30264519
[TBL] [Abstract][Full Text] [Related]
20. Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors.
Santos AP; Santos AC; Castro C; Raposo L; Pereira SS; Torres I; Henrique R; Cardoso H; Monteiro MP
Cancers (Basel); 2018 Aug; 10(9):. PubMed ID: 30150555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
